Join the Birth Control group to help and get support from people like you.
Birth Control News (Page 5)
Related terms: Fertility Control, Anticonception
After Dobbs, a Rise in Out-of-State Patients for Abortion in Washington State
FRIDAY, May 31, 2024 – Following the fall of Roe v. Wade in the summer of 2022, there's been a surge in women from as far away as Texas and Florida traveling to Washington state to have a legal...
New Steps Towards a Male Birth Control Pill
FRIDAY, May 24, 2024 – For decades, the responsibility for birth control has fallen largely on women, but new research suggests a birth control pill for men might one day become a reality. How does...
AAN Issues Guideline for Use of Antiseizure Meds in People of Childbearing Potential
FRIDAY, May 17, 2024 – In a practice guideline issued by the American Academy of Neurology, along with the American Epilepsy Society and the Society for Maternal-Fetal Medicine, recommendations are...
Hormonal Meds for Birth Control, Menopause Linked to Brain Tumors
THURSDAY, March 28, 2024 – The contraceptive injection Depo-Provera and two drugs used for menopause relief could be linked to a heightened risk for brain tumors in some women, a new study warns....
FDA Medwatch Alert: Lupin Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of 2 Lots of Tydemy Due to Out of Specification (OOS) Results at the 12-month Stability Time Point
Baltimore, Maryland, July 28, 2023: Lupin Pharmaceuticals Inc. (Lupin) is voluntarily recalling two (2) lots of Tydemy (Drospirenone, Ethinyl Estradiol and Levomefolate Calcium Tablets...
FDA Approves Opill (norgestrel) OTC Daily Oral Contraceptive
DUBLIN, July 13, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, announced today that the U.S. Food and Drug Administration (FDA) approved ...
FDA Approves Medicines360’s Liletta (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Eight Years
SAN FRANCISCO – Nov. 14, 2022 – Medicines360, a global nonprofit organization with a mission to expand women’s access to quality medicines, announced today that the U.S. Food and Drug Administration ...
FDA Approves Extension of Mirena (levonorgestrel-releasing intrauterine system) Intrauterine Device (IUD) for up to Eight Years of Pregnancy Prevention
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer, a leader in women's healthcare, announced today that the U.S. Food and Drug Administration (FDA) approved a supplemental new drug application (sNDA) that...
FDA Approves Nextstellis (drospirenone and estetrol) Oral Contraceptive for Birth Control
GREENVILLE, N.C., April 16, 2021 /PRNewswire/ – Mayne Pharma announced today that the U.S. Food and Drug Administration (FDA) has approved Nextstellis (3 mg drospirenone [DRSP] and 14.2 mg estetrol...
FDA Approves Phexxi (lactic acid, citric acid and potassium bitartrate) Non-Hormonal Prescription Gel for the Prevention of Pregnancy
SAN DIEGO, May 22, 2020 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced that the U.S. Food and Drug Administration (FDA) has approved Phexxi™ (lactic acid, citric acid and pota...
FDA Approves Twirla (levonorgestrel and ethinyl estradiol) Contraceptive Patch
PRINCETON, N.J., Feb. 14, 2020 (GLOBE NEWSWIRE) – Agile Therapeutics, Inc., (Nasdaq: AGRX) (Agile or the Company), a forward-thinking women’s healthcare company, today announced that the U.S. Food a...
FDA Approves EluRyng (etonogestrel/ethinyl estradiol vaginal ring), the First Generic NuvaRing
BRIDGEWATER, N.J.--(BUSINESS WIRE) December 12, 2019 – Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (AND...
FDA Approves Liletta (levonorgestrel-releasing intrauterine system) to Prevent Pregnancy for up to Six Years
SAN FRANCISCO and DUBLIN October 28, 2019 – Medicines360, a global nonprofit organization with a mission to expand women’s access to quality medicines, and Allergan plc (NYSE: AGN), a leading global p...
Exeltis USA, Inc. Announces the Approval of Slynd (drospirenone), the First and Only Progestin-Only Pill Providing Pregnancy Prevention with a 24/4 Dosing Regimen and 24-hour Missed Pill Window
FLORHAM PARK, N.J., June 6, 2019 /PRNewswire/ – Exeltis USA, Inc. a division of the global pharmaceutical group Insud Pharma, announced today that the US Food and Drug Administration (FDA) has...
FDA Medwatch Alert: Janssen Issues Voluntary Nationwide Recall for One Lot of Ortho-Novum 1/35 and Two Lots of Ortho-Novum 7/7/7 Due to Incorrect Veridate Dispenser Instructions
The Ortho-Novum® product itself remains safe and effective for use with the appropriate dispenser instructionsTITUSVILLE, NJ – November 2, 2018 – Janssen Pharmaceuticals, Inc. has initiated a vo...
Further information
Related condition support groups
Emergency Contraception, Postcoital Contraception
Related drug support groups
Depo-Provera, Nexplanon, Provera, NuvaRing, Mirena, Implanon, levonorgestrel, Sprintec, Loestrin 24 Fe, Yasmin, Lo Loestrin Fe, medroxyprogesterone, Kyleena